Document Classification

Section Type: RESULTS

Text: OFC-treated patients exhibited greater improvements on MCS score (P < 0. 001) vs both placebo and olanzapine), 5 SF-36 dimension scores (general health perception (P < 0. 001) vs placebo ; (P < 0. 001) vs olanzapinel, mental health [P = 0. 001] vs both placebo and olanzapine], role-emotional [P < 0. 001] vs placebo ; [P = 0. 007] vs olanzapine], social functioning [P = 0. 001] vs placebo ; [P = 0. 032] vs olanzapine], and vitality [P = 0. 002] vs placebo ; [P = 0. 011] vs olanzapine]), and QLDS total score (P < 0. 001] vs both placebo and olanzapine).